Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man

AIMS: The aim of the study was to test if pharmacological intervention by valproic acid (VPA) treatment can modulate the fibrinolytic system in man, by means of increased acute release capacity of tissue plasminogen activator (t-PA) as well as an altered t-PA/Plasminogen activator inhibitor -1 (PAI-...

Descripción completa

Detalles Bibliográficos
Autores principales: Saluveer, Ott, Larsson, Pia, Ridderstråle, Wilhelm, Hrafnkelsdóttir, Thórdís J., Jern, Sverker, Bergh, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189785/
https://www.ncbi.nlm.nih.gov/pubmed/25295869
http://dx.doi.org/10.1371/journal.pone.0107582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189785/
https://www.ncbi.nlm.nih.gov/pubmed/25295869
http://dx.doi.org/10.1371/journal.pone.0107582

Ejemplares similares